A new cancer immunotherapy has shown promising results in preclinical studies

A team of researchers has taken a major step toward a new form of cancer immunotherapy. A two-phase vaccine treatment has shown promise in stimulating the immune system against cancer cells in preclinical animal studies. If the therapy proves viable in clinical trials, it could redefine the future of cancer treatments and open up new avenues for personalized medicine.